Unlock and Upgrade

Remove all limits from your Quizzes

You've reached the limit of our free version but can immediately unlock and go pro.

Test your knowledge of Follicular Lymphoma transformed to DLBCL

Which of the following is a potential treatment option that can be used in the relapsed/refractory setting for patients with follicular lymphoma transformed to DLBCL who are NOT eligible for autologous stem cell transplant?

Epcoritamab

Loncastuximab

Selinexor

All the above

Which of the following CAR T-cell therapies is NOT currently recommended for patients with follicular lymphoma transformed to DLBCL?

Axicabtagene ciloleucel

Tisagenlecleucel

Lisocabtagene maraleucel

Ciltacabtagene autoleucel

Which of the following is an effective second-line treatment option for patients with follicular lymphoma transformed to DLBCL who ARE candidates for HDT/ASCR?

R-ICE (rituximab, ifosfamide, carboplatin, and etoposide)

Polatuzumab vedotin in combination with bendamustine and rituximab

Tafasitamab plus lenalidomide

CEOP (cyclophosphamide, etoposide, vincristine, prednisone)

{"name":"Test your knowledge of Follicular Lymphoma transformed to DLBCL", "url":"https://www.quiz-maker.com/QEY7QDU62","txt":"Which of the following is a potential treatment option that can be used in the relapsed\/refractory setting for patients with follicular lymphoma transformed to DLBCL who are NOT eligible for autologous stem cell transplant?, Which of the following CAR T-cell therapies is NOT currently recommended for patients with follicular lymphoma transformed to DLBCL?, Which of the following is an effective second-line treatment option for patients with follicular lymphoma transformed to DLBCL who ARE candidates for HDT\/ASCR?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}

Make your own Quiz